Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Semaglutide 2.4?mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Error
An application error has occurred
This error has been logged to the server event log and should be reviewed.
Error Message: